1. Home
  2. TSHA vs LUNR Comparison

TSHA vs LUNR Comparison

Compare TSHA & LUNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • LUNR
  • Stock Information
  • Founded
  • TSHA 2019
  • LUNR 2013
  • Country
  • TSHA United States
  • LUNR United States
  • Employees
  • TSHA N/A
  • LUNR N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • LUNR Industrial Machinery/Components
  • Sector
  • TSHA Health Care
  • LUNR Industrials
  • Exchange
  • TSHA Nasdaq
  • LUNR Nasdaq
  • Market Cap
  • TSHA 1.4B
  • LUNR 1.4B
  • IPO Year
  • TSHA 2020
  • LUNR N/A
  • Fundamental
  • Price
  • TSHA $4.72
  • LUNR $12.41
  • Analyst Decision
  • TSHA Strong Buy
  • LUNR Buy
  • Analyst Count
  • TSHA 8
  • LUNR 6
  • Target Price
  • TSHA $9.63
  • LUNR $14.00
  • AVG Volume (30 Days)
  • TSHA 11.3M
  • LUNR 9.7M
  • Earning Date
  • TSHA 11-12-2025
  • LUNR 11-13-2025
  • Dividend Yield
  • TSHA N/A
  • LUNR N/A
  • EPS Growth
  • TSHA N/A
  • LUNR N/A
  • EPS
  • TSHA N/A
  • LUNR N/A
  • Revenue
  • TSHA $8,098,000.00
  • LUNR $225,977,000.00
  • Revenue This Year
  • TSHA N/A
  • LUNR $14.43
  • Revenue Next Year
  • TSHA N/A
  • LUNR $45.68
  • P/E Ratio
  • TSHA N/A
  • LUNR N/A
  • Revenue Growth
  • TSHA N/A
  • LUNR 42.86
  • 52 Week Low
  • TSHA $1.05
  • LUNR $6.14
  • 52 Week High
  • TSHA $5.51
  • LUNR $24.95
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 59.56
  • LUNR 59.03
  • Support Level
  • TSHA $4.80
  • LUNR $11.80
  • Resistance Level
  • TSHA $5.51
  • LUNR $13.90
  • Average True Range (ATR)
  • TSHA 0.44
  • LUNR 1.13
  • MACD
  • TSHA 0.04
  • LUNR 0.05
  • Stochastic Oscillator
  • TSHA 66.02
  • LUNR 51.79

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

Share on Social Networks: